Millar D S, Steinbrecher R A, Wieland K, Grundy C B, Martinowitz U, Krawczak M, Zoll B, Whitmore D, Stephenson J, Mibashan R S
Molecular Genetics Section, Thrombosis Research Institute, Chelsea, London, UK.
Hum Genet. 1990 Dec;86(2):219-27. doi: 10.1007/BF00197709.
In a survey of 528 unrelated haemophilia A patients, six partial deletions of the factor VIII (FVIII) gene were detected by Southern blotting. These deletions were further mapped by a combination of Southern blotting and polymerase chain reaction amplification and found to vary in length between 4.7 kb and 57 kb. The frequency of detectable FVIII gene deletions (about 1%) frequency of detectable FVIII gene deletions (about 1%) is thus considerably lower than previously reported. Statistical analysis of currently available data did not provide any evidence for a deletion "'hotspot". Four of the six deletion patients reported here possessed inhibitors. Taken together with previous data, deletion of the FVIII gene was found to be associated with an approximately five-fold higher risk of developing inhibitors compared with other severe haemophiliacs without gene deletions.
在一项对528名无亲缘关系的甲型血友病患者的调查中,通过Southern印迹法检测到6例因子VIII(FVIII)基因的部分缺失。通过Southern印迹法和聚合酶链反应扩增相结合的方法对这些缺失进行了进一步定位,发现其长度在4.7 kb至57 kb之间变化。可检测到的FVIII基因缺失频率(约1%)因此远低于先前报道的频率。对现有数据的统计分析未提供任何关于缺失“热点”的证据。此处报告的6例缺失患者中有4例存在抑制物。结合先前的数据,发现FVIII基因缺失与发生抑制物的风险相比其他无基因缺失的严重血友病患者大约高五倍有关。